XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net sales $ 3,055 $ 1,898 $ 8,271 $ 5,539
Cost of sales 2,037 1,650 5,872 4,839
Gross profit 1,018 248 2,399 700
Selling, general and administrative expenses 122 108 383 332
Amortization of intangibles 29 27 83 81
Restructuring, transaction and integration-related costs 6 34 6 36
Income from operations 861 79 1,927 251
Other income (expense)        
Interest expense (61) (37) (130) (108)
Other income, net 13 12 35 32
Income before income taxes 813 54 1,832 175
Provision for (benefit from) income taxes 193 (15) 423 (75)
Net income 620 69 1,409 250
Net income attributable to noncontrolling interests 13 12 38 33
Net income attributable to Westlake Chemical Corporation $ 607 $ 57 $ 1,371 $ 217
Earnings per common share attributable to Westlake Chemical Corporation:        
Basic (in dollars per share) $ 4.71 $ 0.45 $ 10.65 $ 1.69
Diluted (in dollars per share) $ 4.69 $ 0.45 $ 10.60 $ 1.69
Weighted average common shares outstanding:        
Basic (in shares) 128,060,193 127,701,340 128,053,337 127,872,434
Diluted (in shares) 128,765,814 127,953,907 128,710,097 128,073,066